John Alspaugh
Plastic Surgery · Virginia Beach, VANPI 1063527505
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,411 of the $7,715 with a category attached, or 83.1%. 19 manufacturers reported payments, led by AbbVie at 36.1% of the total.
Across 216 payments — averaging $35.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Musculoskeletal Transplant Foundation Inc.$2K
- Integra Lifesciences Corporation$1K
- Mentor Worldwide LLC$431
- Galderma Laboratories, L.p.$288
- Sientra, Inc.$189
- plus $463 from 13 others
What the payments were for
- Food & beverage$6,41183%
- Other$1,30317%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 132 | $2,787 |
| Musculoskeletal Transplant Foundation Inc. | 17 | $2,181 |
| Integra Lifesciences Corporation | 6 | $1,376 |
| Mentor Worldwide LLC | 17 | $431 |
| Galderma Laboratories, L.p. | 17 | $288 |
| Sientra, Inc. | 8 | $189 |
| Revance Therapeutics, Inc. | 4 | $71 |
| Medela LLC | 2 | $64 |
| Bard Peripheral Vascular, Inc. | 2 | $59 |
| Merz North America, Inc. | 2 | $47 |
| Medtronic | 1 | $44 |
| Kerecis Limited | 1 | $36 |
| Vertex | 1 | $33 |
| Bioventus LLC | 1 | $23 |
| TEI Biosciences Inc | 1 | $19 |
| TELA Bio, Inc. | 1 | $19 |
| Smith+Nephew | 1 | $17 |
| Mimedx Group, Inc. | 1 | $16 |
| Innovation Technologies Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,715 in reported general payments places this provider in the 70th percentile of 121 plastic surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 32 | $307 |
| Ondansetron Hcl | 34 | $110 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $100 |
| Oxycodone Hcl | 12 | $67 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Virginia Beach
- Richard RosenblumVirginia Beach$39K
- John MancollVirginia Beach$19K
- Anna DrzewieckiVirginia Beach$16K
- Michael DenkVirginia Beach$13K
- Eric JablonkaVirginia Beach$12K
- Jonathan JacobsVirginia Beach$8K
- Thomas HubbardVirginia Beach$5K
- Ali MesbahiMcLean$277K
- Vineet MehanFalls Church$244K
- Michael GrantCharlottesville$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.